Israel Englander Puma Biotechnology, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,167,463 shares of PBYI stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,167,463
Previous 3,164,249
0.1%
Holding current value
$12.2 Million
Previous $13.7 Million
22.52%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding PBYI
# of Institutions
99Shares Held
29.5MCall Options Held
842KPut Options Held
32.2K-
Vanguard Group Inc Valley Forge, PA3.49MShares$13.4 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.82MShares$10.8 Million0.78% of portfolio
-
Acadian Asset Management LLC Boston, MA1.96MShares$7.53 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.73MShares$6.66 Million0.01% of portfolio
-
Camber Capital Management LP Boston, MA1.65MShares$6.35 Million0.21% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $175M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...